Skip to main content

Table 4 Secondary endpoints of BOABS Study participants

From: The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting

 

Usual care group

Intervention group

Self-reported health as fair/poor

21/94 (22%)

14/49 (29%)

Nicotine dependency score ≤5 [26]

  

  Baseline

26/50 (52%)

11/27 (41%)

  Final follow-up

34/50 (68%)

18/27 (67%)

Reduced average daily cigarettes by ≥20%

38/74 (51%)

15/35 (43%)

Attempted to quit at any time during the study

36/90 (40%)

27/48 (56%)

  1. Data are number (%) based on the study arm to which participants were originally assigned;
  2. Only included participants who had a nicotine dependency score recorded at baseline and final follow-up.